Compare EVEX & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVEX | CERT |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2020 |
| Metric | EVEX | CERT |
|---|---|---|
| Price | $3.13 | $6.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $6.88 | ★ $12.78 |
| AVG Volume (30 Days) | 1.1M | ★ 2.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.14 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $385,148,000.00 |
| Revenue This Year | N/A | $10.75 |
| Revenue Next Year | N/A | $6.32 |
| P/E Ratio | ★ N/A | $215.33 |
| Revenue Growth | N/A | ★ 8.70 |
| 52 Week Low | $2.83 | $6.32 |
| 52 Week High | $7.70 | $15.38 |
| Indicator | EVEX | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 29.47 | 23.30 |
| Support Level | $2.98 | $6.32 |
| Resistance Level | $3.19 | $7.29 |
| Average True Range (ATR) | 0.21 | 0.40 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 16.44 | 13.36 |
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.